Press release
Celiac Disease Market Revenue Report with Forecast to 2031
The Global Celiac Disease Market is estimated to reach over USD 1,195.5 Mn by 2031, exhibiting a CAGR of 9.8% during the forecast period.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2874
Celiac disease is a chronic autoimmune disorder triggered by the ingestion of gluten, a protein found in wheat, barley, and rye. Upon gluten consumption, the immune system initiates a response that damages the small intestine's lining, leading to the destruction of intestinal villi. This impairment significantly reduces the body's ability to absorb essential nutrients-such as proteins, carbohydrates, lipids, vitamins, and minerals-potentially resulting in malnutrition and other long-term health complications.
The Celiac Disease Market is witnessing substantial growth, driven by increasing disease prevalence, advancements in diagnostic technologies, and rising consumer awareness. Key trends shaping the market include improved diagnosis rates, expansion of the gluten-free product sector, and ongoing research into therapeutic interventions. The market is further propelled by the growing demand for gluten-free dietary alternatives and continuous innovations in disease management solutions.
List of Prominent Players in the Celiac Disease Market:
• Amgen
• Anokion SA
• BioLineRx Ltd
• ChemoCentryx, Inc
• COUR Pharmaceutical
• F. Hoffmann-La Roche Ltd
• ImmunogenX, LLC
• Innovate Biopharmaceuticals
• Takeda Pharmaceutical Company Limited
• Teva Pharmaceutical Industries Ltd.
Market Dynamics
Drivers:
The growth of the Celiac Disease Market is primarily driven by several key factors. The rising prevalence of celiac disease has significantly increased the demand for gluten-free products and therapeutic solutions. Additionally, heightened consumer awareness regarding the health risks associated with gluten consumption has contributed to market expansion. While many individuals receive a formal celiac disease diagnosis, an increasing number of undiagnosed individuals are adopting gluten-free diets due to growing awareness of gluten-related health concerns. Furthermore, advancements in diagnostic technologies are enabling earlier and more accurate detection, leading to a larger diagnosed patient population.
Curious About This Latest Version Of The Report? Enquiry Before Buying:
https://www.insightaceanalytic.com/enquiry-before-buying/2874
Challenges:
Despite its promising growth trajectory, the Celiac Disease Market faces several obstacles. The high cost of gluten-free products presents a financial barrier, restricting access for many patients and their families. Additionally, underdiagnosis remains prevalent, particularly in regions with limited awareness and inadequate knowledge about the disease. Stringent food labeling and regulatory requirements create challenges for gluten-free product manufacturers, increasing operational complexities. Moreover, limited distribution channels and availability of gluten-free products in developing markets hinder market expansion and impact patient adherence to recommended dietary practices.
Regional Trends:
North America holds a leading position in the celiac disease treatment market, supported by a high prevalence of the disease, well-established market players, and substantial healthcare spending. The United States remains the largest contributor to regional market growth, driven by strong consumer demand and robust healthcare infrastructure. Meanwhile, the Asia-Pacific region is projected to witness rapid growth over the forecast period (2023-2032), fueled by increasing disease awareness and expanding population demographics. Within the region, China holds the largest market share, while India is emerging as the fastest-growing market for celiac disease treatments and gluten-free products.
Recent Developments:
• In June 2021, BioLineRx announced the start of a Phase 2b clinical trial for its flagship drug, BL-7010, as a therapy for celiac disease. The experiment will assess the safety and efficacy of BL-7010 in lowering gluten-induced symptoms and gut inflammation in celiac disease patients.
• In September 2022, ChemoCentryx recently announced encouraging results from a Phase 2 clinical trial of a new medication candidate for celiac disease-associated refractory sprue. The study found that refractory sprue, a severe form of celiac disease, showed encouraging results in terms of symptom reduction and intestinal health.
Unlock Your GTM Strategy:
https://www.insightaceanalytic.com/customisation/2874
Segmentation of Celiac Disease Market-
By Treatments-
• Infliximab
• Larazotide Acetate
• Gluten-Free Diet
• Others
By Route of Administration-
• Oral
• Parenteral
By End-Users-
• Hospitals
• Homecare
• Others
By Distribution Channels-
• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa
Get more information:
https://www.insightaceanalytic.com/report/celiac-disease-market/2874
Contact us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.JPG
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Celiac Disease Market Revenue Report with Forecast to 2031 here
News-ID: 3939542 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Lipid Nanoparticles (LNPs) CDMO Market Current Scenario with Future Trends Analy …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Lipid Nanoparticles (LNPs) CDMO Market - (By Product (mRNA, Plasmid DNA (pDNA), siRNA, saRNA, microRNA, and Others), Scale of Operation (Preclinical, Clinical, and Commercial), End-Users (Pharmaceutical Companies, Academic Research Institute, Diagnostic Laboratories)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic, the Global Lipid Nanoparticles (LNPs) CDMO Market…
Non-Muscle Invasive Bladder Cancer Market Developments Covering Immunotherapy En …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Non-muscle Invasive Bladder Cancer Market - (By Treatment Type (Immunotherapy, Chemotherapy, Targeted Therapy), By Cancer Type (Low Grade Bladder Cancer, High Grade Bladder Cancer), By End-user (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Non-muscle Invasive Bladder Cancer Market…
Pharmaceutical Manufacturing Software Market Opportunities Driven by Agile Manuf …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Pharmaceutical Manufacturing Software Market Size, Share & Trends Analysis Report By Deployment Type (On-cloud, On-premise), Application (Large Enterprises, Small and Midsize Enterprises), End User (Biopharmaceutical Companies, Medical Device Companies, Contract Research Organizations, Academic Research Institutions, Others)- Market Outlook And Industry Analysis 2031"
The Global Pharmaceutical Manufacturing Software Market is valued at US$ 2.9 Bn in 2023,…
Portable Power Stations Market Evaluation Featuring Multifunctional Units for Ou …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Portable Power Stations Market"-, By Technology (Lithium-ion, Lead-acid, and Fuel Cell Vehicle (FCV)), By Application (Emergency, Off-grid, and Automotive), By Capacity (Under 300 Wh, 300-600 Wh, Above 600 Wh), and Global Forecasts, 2024-2031 And Segment Revenue and Forecast To 2031."
The Portable Power Stations Market is estimated to reach over USD 1,169.4 million by 2031, exhibiting…
More Releases for Celiac
Celiac Disease Market Emerging Trends and Growth Prospects 2034
Introduction
Celiac disease is a chronic autoimmune disorder triggered by gluten ingestion in genetically susceptible individuals, leading to intestinal damage, malabsorption, and systemic complications. Affecting approximately 1% of the global population, the disease remains underdiagnosed, with many patients suffering from undiagnosed or mismanaged symptoms such as abdominal pain, diarrhea, anemia, osteoporosis, and neurological issues.
The cornerstone of treatment for decades has been the lifelong gluten-free diet (GFD), which requires strict avoidance of…
Celiac Disease Treatment Market
Celiac disease is an autoimmune disorder that affects the small intestine, triggered by the ingestion of gluten-a protein found in wheat, barley, and rye. This condition leads to inflammation and damage in the intestinal lining, which can hinder nutrient absorption and result in various gastrointestinal and systemic symptoms. As awareness of celiac disease grows, so does the demand for effective treatments and dietary solutions. This post delves into the celiac…
Celiac Disease Drugs Market to Record an Exponential CAGR
Celiac Disease Drugs Market report analyses the prospects in the market for several shareholders and aspirants by identifying the high-growth segments, main actions approved by them and Celiac Disease Drugs market recent progressions. The Celiac Disease Drugs market report is prepared after fundamental levels of research regarding the Celiac Disease Drugs Industry.
Celiac Disease Drugs Market by Drugs (First Line of Treatment and Second Line of Treatment) - Global Opportunity Analysis…
Celiac disease Market to Observe Strong Development by 2025
The global Celiac Disease Market is prophesied to rake in a heavy demand on account of three decisive factors such as healthy government initiatives, prevalence of the disease, and increased consumption of foods containing gluten.
Governments of different countries such as the U.K., Canada, New Zealand, Australia, and Argentina and the European Union are expected to accelerative initiatives for the treatment of celiac disease. These governments could provide a strong boost…
Celiac disease market: Global Trends and Forecast Analysis 2025
Celiac disease is an autoimmune disorder in which the surface of the small intestine is damaged by a protein called gluten. Gluten is found in rye, barley, and wheat. Gluten triggers an immune reaction in the small intestine damaging the villi (small finger-like projections in the small intestine which promote absorption). The damage restricts the ability of the body to absorb proteins, nutrients, fats, vitamins, carbohydrates, and minerals. Eventually, this…
Celiac Disease Market Growth is Propelled by the Rising Demand from Millennial a …
Celiac disease is an autoimmune disorder in which the surface of the small intestine is damaged by a protein called gluten. Gluten is found in rye, barley, and wheat. Gluten triggers an immune reaction in the small intestine damaging the villi (small finger-like projections in the small intestine which promote absorption). The damage restricts the ability of the body to absorb proteins, nutrients, fats, vitamins, carbohydrates, and minerals. Eventually, this…
